- Corporate Officers - P
- Pangalos Menelas N
Insider Trading History of Pangalos Menelas N
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Pangalos Menelas N since 2025.
This trader's CIK number is 2001873.
At the time of last reporting, Pangalos Menelas N was the Director of Biogen Inc.. (stock ticker symbol BIIB).
Also see all insider trading activities at Biogen Inc..
Note that in the past
Pangalos Menelas N also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Biogen Inc. (BIIB) by Pangalos Menelas N
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | BIIB | 0 | $0 | 0 | $0 | 2,370 | $0 |
Yearly summary of insider trading at Absci Corp (ABSI) by Pangalos Menelas N
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2026 | ABSI | 112,548 | $406,508 | 0 | $0 | 0 | $0 |
| 2025 | ABSI | 95,785 | $254,788 | 0 | $0 | 0 | $0 |
Insider trading activities at 2 companies by Pangalos Menelas N:
1. Biogen Inc. (BIIB)
2. Absci Corp (ABSI)
Table 1. Insider trading of Biogen Inc. (BIIB) by Pangalos Menelas N
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-06-09 | BIIB | Option Ex | 2,370 | .00 | 0 |
Table 2. Insider trading of Absci Corp (ABSI) by Pangalos Menelas N
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2026-05-13 | ABSI | Buy | 37,453 | 5.36 | 200,748 |
| 2026-02-27 | ABSI | Buy | 75,095 | 2.74 | 205,760 |
| 2025-09-22 | ABSI | Buy | 95,785 | 2.66 | 254,788 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Pangalos Menelas N
(Director of Biogen Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.